Fengxi Liu

668 total citations
23 papers, 554 citations indexed

About

Fengxi Liu is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Fengxi Liu has authored 23 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Biomaterials and 5 papers in Biomedical Engineering. Recurrent topics in Fengxi Liu's work include Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (4 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Fengxi Liu is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (4 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Fengxi Liu collaborates with scholars based in China and Australia. Fengxi Liu's co-authors include Na Zhang, Lixia Feng, Chunxi Liu, Jian Zhang, Min Li, Lili Wang, Donghua Liu, Zhihong Liu, Xiao Li and Juan Liu and has published in prestigious journals such as Biomaterials, International Journal of Pharmaceutics and RSC Advances.

In The Last Decade

Fengxi Liu

21 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengxi Liu China 11 291 264 172 79 55 23 554
Beom Suk Lee South Korea 14 273 0.9× 272 1.0× 246 1.4× 66 0.8× 56 1.0× 21 651
Caixia Ding China 11 181 0.6× 215 0.8× 139 0.8× 103 1.3× 32 0.6× 31 598
Aida Varela-Moreira Netherlands 12 202 0.7× 274 1.0× 149 0.9× 77 1.0× 65 1.2× 16 507
Yoshihisa Kaneda Japan 13 295 1.0× 191 0.7× 115 0.7× 98 1.2× 64 1.2× 36 651
Angela Alexander-Bryant United States 11 318 1.1× 199 0.8× 132 0.8× 59 0.7× 52 0.9× 18 544
Yingwen Hu China 11 206 0.7× 295 1.1× 230 1.3× 48 0.6× 42 0.8× 15 568
Ela Markovsky Israel 11 268 0.9× 298 1.1× 179 1.0× 58 0.7× 115 2.1× 15 696
Alexandra Arranja Netherlands 11 185 0.6× 243 0.9× 216 1.3× 42 0.5× 63 1.1× 21 576
Lucien Bildstein France 7 208 0.7× 215 0.8× 156 0.9× 58 0.7× 67 1.2× 8 462
Yongjun Wang China 5 197 0.7× 223 0.8× 242 1.4× 52 0.7× 45 0.8× 13 472

Countries citing papers authored by Fengxi Liu

Since Specialization
Citations

This map shows the geographic impact of Fengxi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxi Liu more than expected).

Fields of papers citing papers by Fengxi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengxi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxi Liu. The network helps show where Fengxi Liu may publish in the future.

Co-authorship network of co-authors of Fengxi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengxi Liu. A scholar is included among the top collaborators of Fengxi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxi Liu. Fengxi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaoman, Yunmei Song, Mingli Li, et al.. (2025). Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancer. Materials Today Bio. 33. 102012–102012.
2.
3.
Shen, Bowen, et al.. (2024). Drug–drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different CYP3A5 genotypes. Therapeutic Advances in Drug Safety. 15. 1591695389–1591695389. 2 indexed citations
4.
Liu, Fengxi, Xiaoming Zhang, Yilei Yang, et al.. (2024). Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients. Frontiers in Pharmacology. 15. 1458838–1458838. 3 indexed citations
5.
Du, Yue, Shuyu Ren, Yue Li, et al.. (2023). CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Voriconazole in Chinese Kidney Transplant Patients. Annals of Pharmacotherapy. 58(6). 605–613. 5 indexed citations
6.
Yan, Xiaolin, et al.. (2023). IONPs-Based Medical Imaging in Cancer Care: Moving Beyond Traditional Diagnosis and Therapeutic Assessment. International Journal of Nanomedicine. Volume 18. 1741–1763. 12 indexed citations
7.
8.
Zhang, Qian, Ying Fu, Shanshan Cui, et al.. (2019). 5-Acetamido-1-(methoxybenzyl) isatin inhibits tumor cell proliferation, migration, and angiogenesis. RSC Advances. 9(63). 36690–36698. 5 indexed citations
9.
10.
Li, Xiujuan, et al.. (2018). Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus. Pathology & Oncology Research. 25(4). 1645–1652. 9 indexed citations
11.
Liu, Fengxi. (2015). Extraction of Functional Components from Moringa oleifera and Development of Moringa oleifera-Based Products. Food Science. 1 indexed citations
12.
Li, Min, Yongjun Liu, Lixia Feng, et al.. (2015). Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery. Colloids and Surfaces B Biointerfaces. 131. 191–201. 31 indexed citations
13.
Liu, Fengxi. (2014). The role and mechanism of ERK1/2 MPAK pathway in proliferation and migration of Eca109 cell line in vitro.
14.
Liu, Yong-Jun, et al.. (2014). Theranostic Polymeric Micelles for the Diagnosis and Treatment of Hepatocellular Carcinoma. Journal of Biomedical Nanotechnology. 11(4). 613–622. 32 indexed citations
15.
Liu, Chunxi, Fengxi Liu, Lixia Feng, et al.. (2013). The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials. 34(10). 2547–2564. 146 indexed citations
16.
Liu, Fengxi, et al.. (2013). Synthesis, characterization and antitumor evaluation of CMCS–DTX conjugates as novel delivery platform for docetaxel. International Journal of Pharmaceutics. 451(1-2). 41–49. 36 indexed citations
17.
Zhou, Yao, Fengxi Liu, Qiannan Guo, et al.. (2013). Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents. Bioorganic & Medicinal Chemistry Letters. 24(2). 591–594. 54 indexed citations
18.
Liu, Fengxi, Min Li, Chunxi Liu, et al.. (2013). Tumor-Specific Delivery and Therapy by Double-Targeted DTX-CMCS-PEG-NGR Conjugates. Pharmaceutical Research. 31(2). 475–488. 23 indexed citations
19.
Liu, Yongjun, Chunxi Liu, Min Li, et al.. (2013). Polymer–Polymer Conjugation to Fabricate Multi-Block Polymer as Novel Drug Carriers: Poly(lactic acid)–Poly(ethylene glycol)–Poly(L-lysine) to Enhance Paclitaxel Target Delivery. Journal of Biomedical Nanotechnology. 10(6). 948–958. 9 indexed citations
20.
Liu, Donghua, Fengxi Liu, Zhihong Liu, Lili Wang, & Na Zhang. (2011). Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody. Molecular Pharmaceutics. 8(6). 2291–2301. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beom Suk Lee Breakdown of academic impact, for papers by Caixia Ding Breakdown of academic impact, for papers by Aida Varela-Moreira Breakdown of academic impact, for papers by Yoshihisa Kaneda Breakdown of academic impact, for papers by Angela Alexander-Bryant Breakdown of academic impact, for papers by Yingwen Hu Breakdown of academic impact, for papers by Ela Markovsky Breakdown of academic impact, for papers by Alexandra Arranja Breakdown of academic impact, for papers by Lucien Bildstein Breakdown of academic impact, for papers by Yongjun Wang
Rankless by CCL
2026